Posts tagged Biological License Applications.
Blogs
8 minute read
Two cases decided over the last three months have added California[1] and Massachusetts[2] to the list of minority states that hold brand name manufacturers of drugs (“Brand Manufacturers”) liable under state “failure to warn” laws when sued by patients that exclusively used a generic version of the Brand Manufacturer’s drug. These cases follow the US Supreme Court decision in PLIVA, Inc. v. Mensing, 131 S. Ct. 2567 (2011) (“PLIVA”), which held that generic drug manufacturers cannot be held liable for failure to update the safety label of a drug or biologic in ...
Blog Editors
Recent Updates
- The DOJ’s Bulk Sensitive Data Rule and Your Obligation to “Know Your Reporting Requirements”
- Is Your Product Ready to Be Listed? What the Dietary Supplement Listing Act of 2026 Means for Your Business
- New York’s Food Safety and Chemical Disclosure Act: A State-Level Overhaul of GRAS Regulation
- Fighting Fire with Fire: Project Glasswing and AI-Powered Cyber Defense in Health Care, Financial Health and Other Critical Infrastructure
- Microsoft Copilot Health: Another Player In AI-Driven Healthcare